Amarin Corp Plc (AMRN)

[Biobillionair]

VuBru-
A rough model can be assumed using 60%, 80% and estimated patient years Amarin was giving in past presentations. If you assume equal drop out rates in both arms, which I believe is reasonable given Vascepa side effect profile, you can estimate a range of RRR given Amarin's estimated 100% point.

IMO the stock is trading flat due to the low institutional ownership and retailer holders that refuse to part with their Amarin shares. This situation was the direct result of ANCHOR Ad Com. It's over-dramatic to say the stock is "destroyed" but it's certainly ruined any chance it will act like a normal bio going into a huge binary event like 80%.
http://www.nasdaq.com/symbol/amrn/institutional-holdings

I predict Amarin will get re-capitalized some time between 80 & 100% through some kind of business transaction. (new US partner/Europe partner/legal settlement)

If Amarin doesn't announce a continuation today in am, the stock should run late this afternoon. AMRN could fill the gap Monday. Filling the gap should reallocate the institutional/retail ratio. It wouldn't surprise me if Baker Brothers pulls the trigger and Amarin directly places shares with them for > $4.50.

JMO

http://www.nasdaq.com/quotes/institutional-portfolio/baker-bros-advisors-lp-596248


BB